.jpeg)
Regulatory Landscape Affecting Hematology Diagnostics
The hematology diagnostics market is shaped by stringent regulations aimed at ensuring test safety and efficacy. Compliance with standards such as FDA approval and CE marking is mandatory for market access, influencing product development and commercialization timelines.
Manufacturers must invest in rigorous clinical trials and quality assurance to meet these requirements. While these regulations protect patient safety, they also present challenges for innovation speed and market entry, balancing safety with technological advancement.